Middle East respiratory syndrome coronavirus (MERS-CoV)

MERS-CoV map

Latest WHO MERS-CoV global summary and assessment of risk

July 2017 -- Between 2012 and 21 July 2017, 2040 laboratory-confirmed cases of Middle East respiratory syndrome-coronavirus (MERS-CoV) infection were reported to WHO, 82% of whom were reported by the Kingdom of Saudi Arabia. In total, cases have been reported from 27 countries in the Middle East, North Africa, Europe, the United States of America, and Asia. Thus far, no sustained human-to-human transmission has occurred anywhere in the world, however limited non-sustained human-to-human transmission in health-care facilities remains a prominent feature of this virus. WHO continues to work with health authorities in the affected countries.

WHO

WHO publishes MERS-CoV vaccine product profile

New standards for vaccines for MERS-CoV – which has so far killed at least 693 people – have been set by WHO and partners. The “WHO Target Product Profiles for MERS-CoV Vaccines” describes minimum acceptable standards for three vaccines currently under development: one vaccine intended to prevent transmission of this virus from dromedary camels to people; and two vaccines for use in outbreaks of this deadly disease and for longer-term protection of people at high risk.

EPA

Introductory level online course on MERS

Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by a coronavirus (Middle East respiratory syndrome coronavirus, or MERS-CoV).

A new course on MERS is hosted by the new OpenWHO learning platform and consists of 4 interactive modules featuring video lectures, presentations and self-tests. The course is aimed to provide information about what is known about this virus, the disease it causes and the ways to prevent, respond to, and control outbreaks of MERS.

WHO/A. Bhatiasevi
MERS-CoV map 13 April 2017

Infection prevention and control measures are critical

April 2017 -- Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for acute respiratory infections and to carefully review any unusual patterns. Infection prevention and control measures are critical to prevent the possible spread of MERS-CoV in health care facilities.

World Health Organization

fact buffet

2,040Since September 2012, WHO has been notified of 2,040 laboratory-confirmed cases of infection with MERS-CoV.

For more: Latest disease outbreak news

712WHO has been notified of at least 712 deaths related to MERS-CoV since September 2012.

For more: Coronavirus infections news

27Since September 2012, 27 countries have reported cases of MERS-CoV

For more: Fact sheet on MERS-CoV